Cited by 27Drug Solubulity and Delivery SystemsAdvancements in Transdermal Drug DeliveryMesoporous Materials and Catalysis

Glabridin smartPearls—Silica selection, production, amorphous stability and enhanced solubility

Hespeler, David, Kaltenbach, Jonas, Pyo, Sung Min·2019·International Journal of Pharmaceutics

Abstract

Glabridin, a compound in the root extract of Glycyrrhiza glabra, has been identified as an effective tyrosinase inhibitor. Applied on skin, melanin synthesis is inhibited, making glabridin an interesting candidate for skin whitening or for the treatment of age spots. However, main obstaclefor its practical use is its low dermal bioavailability, caused by its poor water solubility. In this work smartPearls technology was used to increase the glabridins water solubility. smartPearls consist of silica particles with mesopores in which actives can be loaded. By this, actives are stabilized in amorphous state and simultaneously finely distributed in nm-range. Both amorphization and nanoization are well known approaches to increase saturation solubilities. In smartPearls these approaches are combined. In the first step, glabridin smartPearls formulation was developed, screening systematically the suitability of 4 different silicas varying in their pore sizes (3, 6, 10, 17 nm). Also, most suited filling level of glabridin was determined (25, 50, 80% referred to total pore volume of respective silica). Silica loading was performed by the immersion-evaporation method, resulting in pores filled with glabridin from bottom to top. By light microscopy, dynamic scanning calorimetry and X-ray diffraction the sample with 6 nm pore size and filling levels of 25% and 50% have been verified to be completely amorphous. Highest physical storage stability of 7 months up to now was obtained for the…

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2019.02.028

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Authors
Hespeler, D., Kaltenbach, J., & Pyo, S. M.
Affiliations
  • Freie Universität Berlin (DE)
  • Karlsruhe Institute of Technology (DE)
Corresponding author
Pyo, Sung Min
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2019-04
Volume
561
Pages
228-235
ISSN
0378-5173 (ISSN-L)
OpenAlex
W2918512420
Cited by
27
References
0
Citations by year
2026: 4 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 4
FWCI
1.28
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
Hans-Böckler-Foundation
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
  • Physical Sciences › Materials Science › Materials Chemistry › Mesoporous Materials and Catalysis
Keywords
glabridin, silica particles, mesoporous silica, amorphous drug stabilization, dermal bioavailability, skin lightening, tyrosinase inhibitors, storage stability, dissolution rate
MeSH terms
Drug Carriers, Drug Stability, Isoflavones, Phenols, Silicon Dioxide, Solubility, Nanoparticles, Drug Liberation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review